Similar Articles |
|
American Family Physician September 1, 2003 Magill et al. |
New Developments in the Management of Hypertension Advances in the management of hypertension have refined our understanding of systolic blood pressure, nutrition, medication selection, and hypertension in special populations. |
American Family Physician October 1, 2002 Konzem et al. |
Controlling Hypertension in Patients with Diabetes Hypertension and diabetes mellitus are common diseases in the United States. Patients with diabetes have a much higher rate of hypertension than would be expected in the general population. Regardless of the antihypertensive agent used, a reduction in blood pressure helps to prevent diabetic complications. |
American Family Physician August 1, 2002 Mark W. Niedfeldt |
Managing Hypertension in Athletes and Physically Active Patients Athletes and other physically active patients should be screened for hypertension and given appropriate therapy if needed. |
American Family Physician August 1, 2002 Daphne P. Bicket |
Using ACE Inhibitors Appropriately Although angiotensin-converting enzyme (ACE) inhibitors have documented clinical benefits in a variety of clinical situations, the disparity between the evidence from clinical trials and bedside medicine is well documented. |
American Family Physician December 1, 2004 McConaghy & Smith |
Outpatient Treatment of Systolic Heart Failure Optimal outpatient treatment of systolic heart failure has three goals that should be pursued simultaneously: (1) control of risk factors for the development and progression of heart failure, (2) treatment of heart failure, and (3) education of patients. |
American Family Physician September 15, 2001 |
Guideline for the Management of Heart Failure Caused by Systolic Dysfunction: Part II. Treatment Treatment recommendations for patients with left ventricular systolic dysfunction... |
American Family Physician June 15, 2005 Hanna & Wenger |
Secondary Prevention of Coronary Heart Disease in Elderly Patients A review of the scientific evidence for the secondary prevention of coronary heart disease in the elderly. |
American Family Physician December 15, 2003 Ezekowitz et al. |
Stroke: Strategies for Primary Prevention Stroke is a leading cause of morbidity and mortality. Every year, approximately 500,000 Americans have a first stroke, and approximately 20 percent die within 30 days. This article summarizes strategies that have been shown to be effective in stroke prevention. |
American Family Physician October 15, 2003 Gavin et al. |
Reducing Cardiovascular Disease Risk in Patients with Type 2 Diabetes By increasing patient awareness of the link between diabetes and heart disease, family physicians can encourage patients to take medications (including aspirin), stop smoking, lower blood pressure, and lower cholesterol and blood glucose levels. |
American Family Physician October 15, 2001 Katherine L. Margo |
Spironolactone in Left-Sided Heart Failure: How Does It Fit In? The familiar diuretic spironolactone has taken on new life as a treatment for left-sided congestive heart failure. More research is necessary to determine the order and combinations of spironolactone and other medications in slowing the progression of this disease... |
American Family Physician June 1, 2006 Wexler & Aukerman |
Nonpharmacologic Strategies for Managing Hypertension Hypertensive therapy interventions in the US, such as lifestyle and dietary modification, often are overlooked. Although some lifestyle modifications may seem to offer only minimal blood pressure-lowering effects, they should not be discounted. |
American Family Physician April 15, 2001 Robert E. Hoyt & Lester Shawn |
Reducing Readmissions for Congestive Heart Failure Hospital admission for congestive heart failure is extremely common and quite expensive, although it is frequently preventable... |
American Family Physician July 1, 2005 Micah L. Thorp |
Diabetic Nephropathy: Common Questions Diabetic nephropathy, or diabetic kidney disease, affects 20% - 30% of patients with diabetes. This article addresses some of the common questions raised by physicians managing patients with this disease. |
American Family Physician March 1, 2006 Satpathy et al. |
Diagnosis and Management of Diastolic Dysfunction and Heart Failure With early diagnosis and proper management the prognosis of diastolic dysfunction is more favorable than that of systolic dysfunction. Distinguishing diastolic from systolic heart failure is essential because the optimal therapy for one may aggravate the other. |
American Family Physician November 15, 2000 Tarik M. Ramahi |
Beta Blocker Therapy for Chronic Heart Failure Recent studies have shown that beta blocker therapy improves survival and reduces hospitalizations in patients who have chronic heart failure and left ventricular systolic dysfunction... |
American Family Physician May 1, 2006 Luma & Spiotta |
Hypertension in Children and Adolescents The prevalence and rate of diagnosis of hypertension in children and adolescents appear to be increasing. Most childhood hypertension, particularly in preadolescents, is secondary to an underlying disorder. |
Nurse Practitioner February 2012 Wood & Gordon |
Preventing CVD in women: The NP's role This article focuses on the new American Heart Association guidelines for preventing cardiovascular disease in women and the nurse practitioner's role in implementing them. |
American Family Physician October 15, 2006 Sharonne N. Hayes |
Preventing Cardiovascular Disease in Women The American Heart Association guidelines for cardiovascular disease prevention in women provide physicians with a clear plan for assessment and treatment of cardiovascular disease risk and personalization of treatment recommendations. |
American Family Physician November 15, 2002 Cynthia M. Williams |
Using Medications Appropriately in Older Adults Finding the right balance between too few and too many drugs will help ensure increased longevity, improved overall health, and enhanced functioning and quality of life for the aging population. |
American Family Physician November 1, 2003 Scow et al. |
Combination Therapy with ACE Inhibitors and Angiotensin-Receptor Blockers in Heart Failure This article reviews the literature and available evidence on the use of ACE inhibitors and angiotensin-receptor blockers in combination for the treatment of patients with congestive heart failure. |
American Family Physician April 1, 2004 Nina Solenski |
Transient Ischemic Attacks: Part II. Treatment Risk factors for stroke should be evaluated in patients who have had a transient ischemic attack. |
American Family Physician July 15, 2000 Showkat A. Haji |
Update on Digoxin Therapy in Congestive Heart Failure Congestive heart failure is a progressive disease with significant morbidity and mortality. Despite advances in the prevention and treatment of cardiovascular diseases, the incidence and prevalence of congestive heart failure have increased in recent years... |
American Family Physician October 15, 2000 Patricia A. Howard & Edward F. Ellerbeck |
Optimizing Beta-Blocker Use After Myocardial Infarction Although beta-adrenergic blockers can significantly reduce mortality after a myocardial infarction, these agents are prescribed to only a minority of patients... |
American Family Physician August 15, 2005 Ward & Hume |
STEPS - New Drug Reviews Olmesartan (Benicar) for Hypertension |
American Family Physician June 1, 2004 Gutierrez & Blanchard |
Diastolic Heart Failure: Challenges of Diagnosis and Treatment The outcomes of ongoing clinical trials may provide much-needed information about diastolic heart failure to move from intuitive treatment to therapy based on evidence that matters: decreased morbidity and mortality and improved quality of life. |
American Family Physician March 15, 2005 Lockman et al. |
Treatment of Cholesterol Abnormalities The relationship between coronary heart disease and elevated cholesterol levels has been recognized for many years, but now studies show an improvement in patient-oriented outcomes in patients receiving drug therapy. |
American Family Physician January 15, 2002 Lori J. Mosca |
Optimal Management of Cholesterol Levels and the Prevention of Coronary Heart Disease in Women Elevated levels of low-density lipoprotein cholesterol and triglycerides and low levels of high-density lipoprotein cholesterol are significant risk factors for coronary heart disease. Abundant data show inadequate utilization of lipid-lowering therapy in women... |
American Family Physician March 15, 2006 Wilson & Sanford |
Amlodipine/Atorvastatin (Caduet) for Preventing Heart Disease Amlodipine/atorvastatin offers no added benefit in safety, tolerability, or effectiveness over amlodipine and atorvastatin taken separately. It has not been shown to improve mortality or morbidity in patients who have hypertension with or without dyslipidemia. |
American Family Physician November 15, 2004 Charles T. Taylor |
Eplerenone (Inspra) for Hypertension Eplerenone, a potassium-sparing diuretic similar to spironolactone, selectively blocks aldosterone to lower blood pressure. However, its safety profile is improved over spironolactone because of reduced progesterone and androgen-receptor effects. |
Nursing Management January 2012 Lawrence et al. |
Type 2 Diabetes: Growing to Epic Proportions Affecting all age groups and all aspects of a person's life, diabetes is a major public health issue worldwide, requiring lifelong behavioral and lifestyle changes and support. |
Nursing May 2010 Debra Castner |
Understanding the stages of chronic kidney disease This article will help you to recognize CKD and understand its stages so you can help your patient to modify risk factors, prevent further kidney damage, and manage complications. First, consider the scope of the problem. |
American Family Physician August 15, 2006 Morris, Hatcher & Reddy |
Digoxin Therapy for Heart Failure: An Update Digoxin therapy has long been used to treat heart failure; however, its effectiveness was not completely known until recently. Results of the Digitalis Investigation Group trial showed that adding digoxin to standard heart failure therapy had no effect on mortality. |
Nurse Practitioner February 2011 Jennifer M. Belavic |
Annual Drug Update: 2010 in Review In 2010, the FDA approved several new drugs and new indications for use in primary care. From new therapies for adults with rheumatoid arthritis to a combination drug for benign prostatic hyperplasia, NPs need to be aware of the latest medications now available. |
American Family Physician November 15, 2004 Snively & Gutierrez |
Chronic Kidney Disease: Prevention and Treatment of Common Complications Family physicians have the opportunity to screen at-risk patients, identify affected patients, and ameliorate the impact of chronic kidney disease by initiating early therapy and monitoring disease progression. |
American Family Physician March 1, 2007 Flood & Fleisher |
Preparation of the Cardiac Patient for Noncardiac Surgery Perioperative myocardial infarction (MI) is a major cause of morbidity and mortality in patients who have noncardiac surgery. |
American Family Physician April 1, 2001 Joan Bedinghaus |
Coronary Artery Disease Prevention: What's Different for Women? Cardiovascular disease is the leading cause of death in women, as well as an important cause of disability, although many women and their physicians underestimate the risk... |
American Family Physician January 1, 2003 Edward Onusko |
Diagnosing Secondary Hypertension Secondary hypertension is elevated blood pressure that results from an underlying, identifiable, often correctable cause. Only about 5 to 10 percent of hypertension cases are thought to result from secondary causes. The ABCDE mnemonic can be used to help determine a secondary cause of hypertension. |
American Family Physician June 1, 2005 O'Brien & Chennubhotla |
Treatment of Edema Major causes of edema include venous obstruction, increased capillary permeability, and increased plasma volume secondary to sodium and water retention. A systematic approach is warranted to determine the underlying diagnosis. |
American Family Physician December 15, 2000 Alan J. Garber |
Attenuating Cardiovascular Risk Factors in Patients with Type 2 Diabetes All cardiovascular risk factors except smoking are more prevalent in patients with type 2 diabetes. In addition to exercise, weight control, aspirin therapy and blood pressure control, therapy to modify lipid profiles is usually necessary... |
Nurse Practitioner July 2010 Kristine A. Scordo |
Treating antiretroviral-induced dyslipidemia in HIV-infected adults Studies indicate that HIV-infected patients (both males and females) may be at an increased risk for the development of cardiovascular disease |
American Family Physician December 1, 2000 William E. Chavey |
The Importance of Beta Blockers in the Treatment of Heart Failure Traditionally, beta blockers have been considered to be contraindicated in patients with heart failure. Recently, however, several large randomized, controlled mortality trials have been stopped early because of the effects of beta blockers... |
American Family Physician December 1, 2000 Assad Movahed |
Beta Blockers and Congestive Heart Failure Heart failure is a complex condition, and its treatment requires consideration of two separate goals: symptom relief and tertiary prevention... |
American Journal of Nursing May 2009 Kristen J. Overbaugh |
Acute Coronary Syndrome Coronary artery disease, in which atherosclerotic plaque builds up inside the coronary arteries and restricts the flow of blood (and therefore the delivery of oxygen) to the heart, continues to be the number-one killer of Americans. |
Nursing March 2011 Ali & Gray-Vickrey |
Limiting the Damage From Acute Kidney Injury This article will discuss your role in early detection and management of AKI with an emphasis on care for older adults. |
American Family Physician January 15, 2004 John Smucny |
Does a Low-Sodium Diet Reduce Blood Pressure? Reducing sodium intake does lead to a slightly lower average blood pressure. However, no evidence from controlled trials proves that reducing sodium intake decreases morbidity or mortality, or proves that modest sodium restriction is harmful. |
Nursing February 2010 Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
American Family Physician January 15, 2006 Hollander-Rodriguez & Calvert |
Hyperkalemia Hyperkalemia is a potentially life-threatening metabolic problem caused by inability of the kidneys to excrete potassium, impairment of the mechanisms that move potassium from the circulation into the cells, or a combination of these factors. |
American Family Physician November 1, 2005 Snyder & Pendergraph |
Detection and Evaluation of Chronic Kidney Disease Early treatment of chronic kidney disease and its complications may delay or prevent the development of end-stage renal disease. Consequently, detection of chronic kidney disease should be a priority for family physicians. |
AskMen.com September 1, 2003 Mike Davison |
Do You Have High Blood Pressure? With approximately 58 million -- or one in four -- American adults suffering from high blood pressure, how do you know for certain if you are at risk? Arm yourself with the facts and find out. |
Nurse Practitioner November 2011 Tracy Brazziel et al. |
Stopping the Wave of PAD Early detection and diagnosis of atherosclerotic disease is imperative. Here, learn the risk factors, screening and diagnosis for this disease. |